EAACI Congress 2025
BackTPS58 - Allergen immunotherapy 05
Sunday 15 Jun, 12:45 PM -
13:45 PM Glasgow, United Kingdom
Poster Zone
Thematic Poster Session
Advantage of IgG reactivity testing for the analytical quantification of allergoids
Allergoids: Characterising Identity Pre- and Post- Modification Using Compendial and Novel Methods
BDNF as a biomarker for evaluating clinical response in allergic rhinitis patients undergoing allergen-specific immunotherapy
Comparative analysis of extracts from Cupressus arizonica and Juniperus ashei pollens
Consistent long term benefit of allergen immunotherapy in patients with allergic rhinitis
Effectiveness and Safety Study of Subcutaneous Immunotherapy for Respiratory Allergy to Dermatophagoides and Lepidoglyphus Destructor
Nationwide pivotal registry study on house dust mite immunotherapy in allergic rhinitis patients with or without asthma in China (NAVIGATOR)
Potency of Dermatophagoides spp SLIT tablet compared to US standardized mite in ID testing
Safety and Efficacy of VIT against Wasp Venom in Patients Older than 60 Years
Study of Efficacy of Rush Sub Lingual Immunotherapy (RSLIT) in Cases of Severe Persistent Allergic Rhinitis
The mental health of adolescent patients with cat allergy improves with rapid dosing of depigmented cat allergoids
The value of TNF and IL1RN genes in predicting the clinical efficacy of SCIT in children with asthma
Tumor Necrosis Factor Receptor 2 (TNFR2) is crucial for the efficacy of Allergen-Specific Immunotherapy in a Pre-clinical Murine Model
Validation of a novel serum-based basophil activation test (iBAT) to evaluate efficacy of a pivotal Phase III PQ Grass immunotherapy trial
Аllergen-specific immunotherapy in patients with allergic rhinitis
